Correction: Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients
暂无分享,去创建一个
Dirk Repsilber | Anna Telaar | Gerhard Walzl | Gillian F. Black | Shreemanta K. Parida | Stefan H. E. Kaufmann | Jeroen Maertzdorf | January Weiner | Robert P. Mohney | S. Kaufmann | D. Repsilber | R. Mohney | G. Walzl | J. Weiner | G. Black | S. Parida | C. Ganoza | Cordelia Arndt-Sullivan | Christian A. Ganoza | Kellen C. Faé | J. Maertzdorf | A. Telaar | K. Faé | C. Arndt-Sullivan
[1] Sirish L. Shah,et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. , 2009, Journal of proteome research.
[2] Dirk Repsilber,et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis , 2007, Journal of Molecular Medicine.
[3] K. Chida,et al. Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis , 2012, Clinical and Vaccine Immunology.
[4] J. van Staden,et al. Plants used for stress-related ailments in traditional Zulu, Xhosa and Sotho medicine. Part 1: Plants used for headaches. , 1994, Journal of ethnopharmacology.
[5] Qing Yang,et al. Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[6] S. Gangal,et al. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. , 1990, The American review of respiratory disease.
[7] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[8] G. Mills,et al. Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.
[9] R. Weinshilboum,et al. Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.
[10] B. Vickery,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2011, Pediatrics.
[11] U. Grohmann,et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease , 2008, Nature.
[12] Guowang Xu,et al. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Philippe Glaziou,et al. Tuberculosis control and elimination 2010–50: cure, care, and social development , 2010, The Lancet.
[14] Christian Baumgartner,et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. , 2008, The Journal of clinical investigation.
[15] R. Wilkinson,et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.
[16] U. Grohmann,et al. Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.
[17] E. Bateman,et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area , 2005, Thorax.
[18] J. Ernst,et al. Tuberculosis pathogenesis and immunity. , 2012, Annual review of pathology.
[19] M. Avila,et al. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. , 1998, Gastroenterology.
[20] C. MacKenzie,et al. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects , 2008, Journal of cellular and molecular medicine.
[21] L. Boon,et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy , 2007, Nature Medicine.
[22] J. Arm,et al. Cytosolic Phospholipase A2 Participates with TNF-α in the Induction of Apoptosis of Human Macrophages Infected with Mycobacterium tuberculosis H37Ra1 , 2001, The Journal of Immunology.
[23] Anne M. Evans,et al. Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.
[24] J. Nicholson,et al. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. , 2003, The Analyst.
[25] 杨军,et al. Plasma Phospholipid Metabolic Profiling and Biomarkers of Type 2 Diabetes Mellitus Based on High Performance Liquid Chromatography/Electrospray Mass Spectrometry and Multivariate Statistical Analysis , 2005 .
[26] G. Schmitz,et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.
[27] Jeff E. Mold,et al. Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease , 2010, Science Translational Medicine.
[28] M. Rudnicki,et al. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. , 2001, Kidney international. Supplement.
[29] J. Utzinger,et al. Global metabolic responses of mice to Trypanosoma brucei brucei infection , 2008, Proceedings of the National Academy of Sciences.
[30] L. Allen. Stem cells. , 2003, The New England journal of medicine.
[31] M. Milburn,et al. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] P. Calder,et al. Does glutamine contribute to immunosuppression after major burns? , 1990, The Lancet.
[33] G. Prendergast,et al. Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape , 2008, Immunological reviews.
[34] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[35] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[36] J. Stypmann,et al. Granulocyte colony–stimulating factor–induced blood stem cell mobilisation in patients with chronic heart failure , 2005, Basic Research in Cardiology.
[37] Christian Gieger,et al. A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.
[38] Xianlin Han,et al. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.
[39] B. Baban,et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. , 2010, Immunity.
[40] Michael Platten,et al. Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite , 2005, Science.
[41] C. Unger,et al. Lipids in Health and Disease Effects of 2 or 5 Consecutive Exercise Days on Adipocyte Area and Lipid Parameters in Wistar Rats , 2022 .
[42] D. Munn,et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.
[43] W. Chang,et al. Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction , 1999, Clinical and experimental immunology.
[44] Christopher D. Rithner,et al. Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. , 2011, Journal of proteome research.
[45] T. Y. Chan,et al. Vitamin D Deficiency and Susceptibility to Tuberculosis , 2000, Calcified Tissue International.
[46] J. Andrade,et al. Biology and Clinical Uses , 2013 .
[47] V. Hack,et al. Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine , 1996, Journal of Molecular Medicine.
[48] Sang-Nae Cho,et al. NMR-based Metabolomic Profiling in Mice Infected with Mycobacterium tuberculosis , 2011 .
[49] A. Elfarra,et al. In Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major Metabolites , 2006, Drug Metabolism and Disposition.
[50] R. Cox,et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.
[51] L. Romics,et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. , 2004, Atherosclerosis.
[52] Trinad Chakraborty,et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. , 2006, The Journal of clinical investigation.
[53] S. Wisniewski,et al. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. , 1998, Journal of neurotrauma.
[54] Corey D. DeHaven,et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.
[55] D Repsilber,et al. Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.
[56] Ignacio González,et al. integrOmics: an R package to unravel relationships between two omics datasets , 2009, Bioinform..
[57] D. Fuchs,et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. , 2007, Blood.
[58] N. Enomoto,et al. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[59] M. Sitkovsky,et al. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. , 2003, Blood.
[60] L. To,et al. The biology and clinical uses of blood stem cells. , 1997, Blood.
[61] K. Nishioka,et al. Physiologic role of the complement system in host defense, disease, and malnutrition. , 1998, Nutrition.
[62] M. Graeber. Biomarkers for Parkinson's disease , 2009, Experimental Neurology.
[63] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[64] W. Matson,et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.
[65] R. K. Shepherd,et al. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. , 1997, The Journal of clinical investigation.
[66] D. Munn,et al. Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.
[67] Christian Gieger,et al. A genome-wide association study of metabolic traits in human urine , 2011, Nature Genetics.
[68] D. Munn,et al. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. , 2009, Blood.
[69] Albert J. Fornace,et al. Metabolomic Analysis in Severe Childhood Pneumonia in The Gambia, West Africa: Findings from a Pilot Study , 2010, PloS one.
[70] Frederick P Roth,et al. Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.
[71] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[72] A. Schwenk,et al. Tuberculosis, malnutrition and wasting. , 2000, Current opinion in clinical nutrition and metabolic care.
[73] B. Baban,et al. Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression. , 2011, The Journal of infectious diseases.
[74] B. Baban,et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. , 2004, The Journal of clinical investigation.
[75] R. Wilkinson,et al. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.